Universal flu vaccine under development
11 May, 2016Vaccitech has received £10m to take a universal flu vaccine, as well as a number of other vaccines that trigger the immune response needed to prevent or treat a range of serious diseases, through clinical trials.
Natural antibodies could combat devil facial tumour disease
04 May, 2016Scientists believe they can stop Tasmanian devil facial tumour disease using natural antibodies derived from a surprising source — the devil's own immune system.
Swift drug screening with a small device
27 April, 2016UQ researchers have created a high-density microbioreactor array — a credit card-sized device that enables cells to be cultured under thousands of different conditions simultaneously, speeding up drug screening.
Guidelines for xenotransplantation research open for consultation
27 April, 2016The NHMRC has opened public consultation on draft guidelines for the ethical review and conduct of clinical trials involving xenotransplantation — the transplantation of living cells, tissues or organs from one species to another (in this case, from animals to humans).
Cell biology expert to investigate inflammation in cancer
13 April, 2016An expert in the relationship between chronic inflammation and the development of cancers will be leading a new research laboratory collaboration between South Australia's Centre for Cancer Biology and Singapore's Agency for Science, Technology and Research.
Genetic antibiotic resistance mechanism continues to spread
12 April, 2016A recently discovered genetic mechanism allowing bacteria to develop and transfer resistance to colistin — one of the last-resort antibiotics — has been present in countries across the world for more than a decade, according to presenters at ECCMID 2016.
T cells bully influenza virus into submission
01 April, 2016 by Adam FloranceAustralian researchers are at the forefront of developing a vaccine which could lead to lifelong immunity against the influenza virus.
An improved vaccine for World TB Day?
24 March, 2016Two proteins from the tuberculosis bacterium are showing promising results in investigations in mice for a new vaccine.
Working together to unleash killer T cells
16 March, 2016Researchers have discovered how two pathways cooperate to unleash the immune system's assassins, called cytotoxic or 'killer' T cells.
Making blood vessels from stem cells
16 March, 2016Patients suffering from heart failure, peripheral artery disease or stroke could benefit from stem cell-based treatment in the future.
A new kind of stem cell
07 March, 2016Scientists have discovered a new kind of stem cell that could lead to advances in regenerative medicine, as well as offer new ways to study birth defects and other reproductive problems.
What makes bats immune to lethal diseases?
24 February, 2016Researchers have uncovered that bats have the unique ability to carry but remain unaffected by lethal diseases.
R&D refund will help support MSC trial
17 February, 2016Stem cell company Cynata Therapeutics has received an R&D Tax Incentive refund of $932,580.65 for the 2014–15 financial year.
A handheld concussion detection device
10 February, 2016Royal Philips and Banyan Biomarkers will develop and commercialise a handheld blood test that can be used to detect mild traumatic brain injury (concussion).
Predicting cancer immunotherapy response
22 January, 2016IRX Therapeutics and ImmunID have entered into a collaboration to predict patients' response to the IRX-2 immunotherapy candidate using the ImmunTraCkeR assay.
